A New World disease: Dual diagnostic challenges in travelers returning from Costa Rica
DOI:
https://doi.org/10.25251/gab6mm81Keywords:
leishmania, new world leishmaniasis, parasitic infections, travel-associated infectionsAbstract
Cutaneous diseases in returning travelers encompass a wide spectrum of etiologies and often pose diagnostic challenges. We present the cases of a 50-year-old man and a 57-year-old woman who presented with a 3-month history of erythematous, ulcerated plaques with well-defined elevated borders and a necrotic center on the lower limbs that began 3 weeks after returning from vacation in Costa Rica. Cutaneous biopsy revealed epidermal ulceration and extensive caseating granulomas throughout the full thickness of the dermis. Giemsa staining revealed no amastigotes. Microbiological examinations identified Leishmania braziliensis and excluded mycobacteria and fungi. The diagnosis of cutaneous leishmaniasis was established. Owing to clinical severity and antimonial unavailability, the man was treated with liposomal amphotericin B. The woman underwent surgical excision of the single lesion, along with oral fluconazole. Complete resolution was documented in both patients. These cases, which posed diagnostic and therapeutic challenges, highlight that cutaneous leishmaniasis, in all its versatile and often perplexing presentations, is a parasitic infection that should always be considered in dermatologic patients returning from vacation in endemic countries.
References
1. Trufant JW, Lewin JM, Hale CS, Meehan SA, Pomeranz MK. New world cutaneous leishmaniasis. Dermatol Online J. 2014;20:13030/qt6bc5398b. [PMID: 25526331].
2. Gurel MS, Tekin B, Uzun S. Cutaneous leishmaniasis: A great imitator. Clin Dermatol. 2020;38:140-151. [PMID: 32513395].
3. Schwartz E, Hatz C, Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis. 2006;6:342-349. [PMID: 16728320].
4. Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7:e35671. [PMID: 22693548].
5. de Vries HJC, Schallig HD. Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments. Am J Clin Dermatol. 2022;23:823-840. [PMID: 36103050].
6. Handler MZ, Patel PA, Kapila R, et al. Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management. J Am Acad Dermatol. 2015;73:911-928. [PMID: 26568336].
7. Pfarr KM, Krome AK, Al-Obaidi I, et al. The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use. Parasit Vectors. 2023;16:394. [PMID: 36859332].
8. Chivinski J, Nathan K, Naeem F, Ekmekjian T, Libman MD, Barkati S. Intravenous Liposomal Amphotericin B Efficacy and Safety for Cutaneous and Mucosal Leishmaniasis: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2023;10:ofad348. [PMID: 37520422].
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Cláudia Brazão, João Borges-Costa, Sofia Antunes-Duarte, Dora Mancha, Lanyu Sun, Tiago Marques, Maria João Gargaté, Anabela Vilares, Tânia Reis, Pedro de Vasconcelos, Luís Soares-de-Almeida, Paulo Filipe (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.